MACDONALD MARIANN T 4
4 · ENDO PHARMACEUTICALS HOLDINGS INC · Filed Aug 11, 2004
Insider Transaction Report
Form 4
MACDONALD MARIANN T
Executive Vice President
Transactions
- Sale
Common Stock, par value $.01
2004-08-09$17.46/sh−1,121,482$19,581,076→ 0 total - Exercise/Conversion
Common Stock, par value $.01
2004-08-09$2.42/sh+40,029$96,870→ 1,121,482 total - Exercise/Conversion
Common Stock, par value $.01
2004-08-09$2.42/sh+1,081,453$2,617,116→ 1,081,453 total - Exercise/Conversion
Class C3 Stock Option
2004-08-09−40,029→ 1,345,249 totalExercise: $2.42From: 2004-08-09Exp: 2007-08-26→ Common Stock (40,029 underlying) - Exercise/Conversion
Class C2 Stock Option
2004-08-09−1,081,453→ 49,182 totalExercise: $2.42From: 2004-08-09Exp: 2007-08-26→ Common Stock (1,081,453 underlying)
Footnotes (3)
- [F1]The exercisability of 1,081,453 Class C2 Options was accelerated in connection with an offering of shares that closed on August 9, 2004. The remaining options become exercisable upon the ealier of an Exit Event (as defined in the underlying option plan as filed with the SEC) or January 1, 2006.
- [F2]Common Stock held by Endo Pharma LLC. The exercise of these stock options did not result in the issuance of additional Common Stock by the Issuer.
- [F3]The exercisability of 40,029 Class C3 Options was accelerated in connection with an offering of shares that closed on August 9, 2004. The remaining options become exercisable upon the ealier of an Exit Event (as defined in the underlying option plan as filed with the SEC) or January 1, 2006.